Blackstone to acquire Australian clinical trials specialist Nucleus Network

Blackstone to acquire Australian clinical trials specialist Nucleus Network

Photo: Nucleus Network website

Alternative asset manager Blackstone on Friday announced that its private equity funds have entered into a definitive agreement to acquire Nucleus Network, the largest phase one clinical trial provider in Australia.